Endologix Comments On NEJM Study Highlighting Advantages Of Minimally Invasi
0 Comments |
Share |
101 Views |
Problem? |
02/06/08
Linked From Medical News Today
:
Endologix, Inc. (Nasdaq:ELGX), developer and manufacturer of the Powerlink(R) System endoluminal stent graft (ELG) for the minimally invasive treatmen